Onychomycose (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Onychomycose" in French language version.

refsWebsite

Global rank French rank

23nih.gov

4^th place

12^th place

17wiley.com

222^nd place

129^th place

4sciencedirect.com

149^th place

80^th place

4doi.org

2^nd place

3^rd place

2issn.org

57^th place

4^th place

2informahealthcare.com

low place

5,838^th place

1chu-rouen.fr

low place

3,450^th place

1univ-lorraine.fr

low place

1,480^th place

1bmj.com

1,226^th place

347^th place

1sgmjournals.org

low place

5,643^rd place

1karger.com

4,489^th place

1,746^th place

1cynosure.fr

low place

1oxfordjournals.org

1,389^th place

508^th place

1wikipedia.org

low place

1acs.org

1,248^th place

778^th place

1mdpi.com

2,912^th place

1,010^th place

acs.org

pubs.acs.org

(en) Konstantia Adam, « Antifungal Activities of Origanum vulgare subsp. hirtum, Mentha spicata, Lavandula angustifolia, and Salvia fruticosa Essential Oils against Human Pathogenic Fungi », J Agric Food Chem, n^o 46,‎ 1998, p. 1739–1745. (lire en ligne)

bmj.com

(en) Eisman S, Sinclair R. « Fungal nail infection: diagnosis and management » BMJ 2014;348:g1800 DOI 10.1136/bmj.g1800 PMID 24661991

chu-rouen.fr

Page Onychomycose sur CISMeF.

cynosure.fr

pro.cynosure.fr

(en) Hamish Dow, « Onychomycosis and nail dystrophy treated with the PinPointe FootLaser », Podiatry Now Magazine,‎ juin 2011, p. 24-27 (lire en ligne [PDF])

doi.org

dx.doi.org

(en) Eisman S, Sinclair R. « Fungal nail infection: diagnosis and management » BMJ 2014;348:g1800 DOI 10.1136/bmj.g1800 PMID 24661991
S. Amir Yazdanparast, « Arthroconidia production in Trichophyton rubrum and a new ex vivo model of onychomycosis », Journal of Medical Microbiology, vol. 55, n^o 11,‎ 11 janvier 2006, p. 1577-1581 (ISSN 0022-2615 et 1473-5644, DOI 10.1099/jmm.0.46474-0, lire en ligne, consulté le 26 décembre 2013)
(en) Barak O, Asarch A, Horn T. « PAS is optimal for diagnosing onychomycosis » J Cutan Pathol. 2010;37:1038-40. PMID 20412344 DOI 10.1111/j.1600-0560.2010.01545.x
(en) Hammer KA, Carson CF, Riley TV, « In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi », J Antimicrob Chemother, vol. 50, n^o 2,‎ 2002, p. 195-9. (PMID 12161399, DOI 10.1093/jac/dkf112, lire en ligne [html]) modifier

informahealthcare.com

(en) M. Soković, « Antifungal Activity of the Essential oil of Thymus vulgaris L. and Thymol on Experimentally Induced Dermatomycoses », Drug Development and Industrial Pharmacy,‎ 2008 (lire en ligne)
(en) Yin Z, Xu J, Luo D, « A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole » J Dermatolog Treat. 2012;23:449-52. PMID 21801094

issn.org

portal.issn.org

S. Amir Yazdanparast, « Arthroconidia production in Trichophyton rubrum and a new ex vivo model of onychomycosis », Journal of Medical Microbiology, vol. 55, n^o 11,‎ 11 janvier 2006, p. 1577-1581 (ISSN 0022-2615 et 1473-5644, DOI 10.1099/jmm.0.46474-0, lire en ligne, consulté le 26 décembre 2013)
(en) Adam S Landsman, Alan H Robbins, Paula F Angelini, Catherine C Wu, Jeremy Cook, Mary Oster, Eric S Bornstein, « Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure », Journal of the American Podiatric Medical Association, vol. 100, n^o 3,‎ juin 2010, p. 166-177 (ISSN 1930-8264, PMID 20479446)

karger.com

(en) Paul C, Coustou D, Lahfa M, Bulai-Livideanu C et al. « A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosis » Dermatology 2013;227:157-64. PMID 24051622

mdpi.com

(en) Marina D. Soković, « Chemical Composition of Essential Oils of Thymus and Mentha Species and Their Antifungal Activities », Molecules,‎ 2008 (lire en ligne)

nih.gov

ncbi.nlm.nih.gov

(en) Faergemann J, Correia O, Nowicki R, Ro BI, « Genetic predisposition—understanding underlying mechanisms of onychomycosis » J Eur Acad Dermatol Venereol. 2005;19:17-9. PMID 16120201
(en) Eisman S, Sinclair R. « Fungal nail infection: diagnosis and management » BMJ 2014;348:g1800 DOI 10.1136/bmj.g1800 PMID 24661991
(en) Gupta AK, Taborda P, Taborda V. et al. « Epidemiology and prevalence of onychomycosis in HIV-positive individuals » Int J Dermatol. 2000;39:746-53. PMID 11095193
(en) Gupta AK, Lynde CW, Jain HC, Sibbald RG. et al. « A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study » Br J Dermatol. 1997;136:786-9 PMID 9205520
(en) Gupta AK, Konnikov N, MacDonald P. et al. « Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey » Br J Dermatol. 1998;139:665-71. PMID 9892911
(en) Gupta AK, Gupta MA, Summerbell RC. et al. « The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease » J Eur Acad Dermatol Venereol. 2000;14:466-9. PMID 11444267
(en) Barak O, Asarch A, Horn T. « PAS is optimal for diagnosing onychomycosis » J Cutan Pathol. 2010;37:1038-40. PMID 20412344 DOI 10.1111/j.1600-0560.2010.01545.x
(en) Hay RJ, « The future of onychomycosis therapy may involve a combination of approaches » Br J Dermatol. 2001;145(Suppl 60):3-8. PMID 11777262
(en) Baran R, Feuilhade M, Combernale P et al. « A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region » Br J Dermatol. 2000;142:1177-83. PMID 10848743
(en) Lecha M, Effendy ‘I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R, « Taskforce on onychomycosis education. Treatment options-development of consensus guidelines » J Eur Acad Dermatol Venereol. 2005;19(Suppl 1):25-33. PMID 16120203
(en) Gupta AK, Baran R, « Ciclopirox nail lacquer solution 8% in the 21st century » J Am Acad Dermatol. 2000;43(Suppl):S96-102. PMID 11051138
(en) Paul C, Coustou D, Lahfa M, Bulai-Livideanu C et al. « A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosis » Dermatology 2013;227:157-64. PMID 24051622
(en) Crawford F, Hollis S, « Topical treatments for fungal infections of the skin and nails of the foot » Cochrane Database Syst Rev. 2007;3:CD001434. PMID 17636672
(en) Hay RJ, Mackie RM, Clayton YM, « Tioconazole nail solution—an open study of its efficacy in onychomycosis » Clin Exp Dermatol. 1985;10:111-5. PMID 3156698
(en) Elewski BE, Rich P, Pollak R. et al. « Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies » J Am Acad Dermatol. 2013;68:600-8. PMID 23177180
(en) Adam S Landsman, Alan H Robbins, Paula F Angelini, Catherine C Wu, Jeremy Cook, Mary Oster, Eric S Bornstein, « Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure », Journal of the American Podiatric Medical Association, vol. 100, n^o 3,‎ juin 2010, p. 166-177 (ISSN 1930-8264, PMID 20479446)
(en) Hammer KA, Carson CF, Riley TV, « In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi », J Antimicrob Chemother, vol. 50, n^o 2,‎ 2002, p. 195-9. (PMID 12161399, DOI 10.1093/jac/dkf112, lire en ligne [html]) modifier
(en) Flores FC, « Antifungal activity of nanocapsule suspensions containing tea tree oil on the growth of Trichophyton rubrum », Mycopathologia, n^o 175,‎ avril 2013 (lire en ligne)
(en) Buck DS, « Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole », J Fam Pract, n^o 38,‎ juin 1994 (lire en ligne)
(en) Havu V, Brandt H, Heikkilä H. et al. « A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis » Br J Dermatol. 1997;136:230-4. PMID 9068738
(en) Gupta AK, Ryder JE, Johnson AM, « Cumulative eta-analysis of systemic antifungal agents for the treatment of onychomycosis » Br J Dermatol. 2004;150:537-44. PMID 15030339
(en) Yin Z, Xu J, Luo D, « A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole » J Dermatolog Treat. 2012;23:449-52. PMID 21801094
(en) Brown SJ, « Efficacy of fluconazole for the treatment of onychomycosis » Ann Pharmacother. 2009;43:1684-91. PMID 19776299

oxfordjournals.org

jac.oxfordjournals.org

(en) Hammer KA, Carson CF, Riley TV, « In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi », J Antimicrob Chemother, vol. 50, n^o 2,‎ 2002, p. 195-9. (PMID 12161399, DOI 10.1093/jac/dkf112, lire en ligne [html]) modifier

sciencedirect.com

Chabasse D & Pihet M (2014) Les onychomycoses à moisissures. Journal de mycologie médicale, 24(4), 261-268|résumé.
(en) Gupta AK, Baran R, « Ciclopirox nail lacquer solution 8% in the 21st century » J Am Acad Dermatol. 2000;43(Suppl):S96-102. PMID 11051138
(en) Elewski BE, Rich P, Pollak R. et al. « Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies » J Am Acad Dermatol. 2013;68:600-8. PMID 23177180
(en) F Şahin, « Biological activities of the essential oils and methanol extract of Origanum vulgare ssp. vulgare in the Eastern Anatolia region of Turkey », Food Control,‎ 2004 (lire en ligne)

sgmjournals.org

jmm.sgmjournals.org

S. Amir Yazdanparast, « Arthroconidia production in Trichophyton rubrum and a new ex vivo model of onychomycosis », Journal of Medical Microbiology, vol. 55, n^o 11,‎ 11 janvier 2006, p. 1577-1581 (ISSN 0022-2615 et 1473-5644, DOI 10.1099/jmm.0.46474-0, lire en ligne, consulté le 26 décembre 2013)

univ-lorraine.fr

docnum.univ-lorraine.fr

Soorajee A, Rôle du Pharmacien d’officine dans la prise en charge des onychomycoses. adaptation des stratégies selon l’origine géographique, Nancy, France, Université de Lorraine, Faculté de Pharmacie, 2012, 155 p. (lire en ligne), p. 19

wikipedia.org

fr.wikipedia.org

(en) Hammer KA, Carson CF, Riley TV, « In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi », J Antimicrob Chemother, vol. 50, n^o 2,‎ 2002, p. 195-9. (PMID 12161399, DOI 10.1093/jac/dkf112, lire en ligne [html]) modifier

wiley.com

onlinelibrary.wiley.com

Pietro Nenoff, Constanze Krüger, Gabriele Ginter-Hanselmayer, Hans-Jürgen Tietz (2014) Mycology – an update. Part 1: Dermatomycoses: Causative agents, epidemiology and pathogenesis
B Sigurgeirsson & Ó Steingrímsson (2003) Risk factors associated with onychomycosis ; 17 December 2003 | DOI: 10.1111/j.1468-3083.2004.00851.x
(en) Faergemann J, Correia O, Nowicki R, Ro BI, « Genetic predisposition—understanding underlying mechanisms of onychomycosis » J Eur Acad Dermatol Venereol. 2005;19:17-9. PMID 16120201
(en) Gupta AK, Taborda P, Taborda V. et al. « Epidemiology and prevalence of onychomycosis in HIV-positive individuals » Int J Dermatol. 2000;39:746-53. PMID 11095193
(en) Gupta AK, Konnikov N, MacDonald P. et al. « Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey » Br J Dermatol. 1998;139:665-71. PMID 9892911
(en) Gupta AK, Gupta MA, Summerbell RC. et al. « The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease » J Eur Acad Dermatol Venereol. 2000;14:466-9. PMID 11444267
(en) Barak O, Asarch A, Horn T. « PAS is optimal for diagnosing onychomycosis » J Cutan Pathol. 2010;37:1038-40. PMID 20412344 DOI 10.1111/j.1600-0560.2010.01545.x
(en) Hay RJ, « The future of onychomycosis therapy may involve a combination of approaches » Br J Dermatol. 2001;145(Suppl 60):3-8. PMID 11777262
(en) Baran R, Feuilhade M, Combernale P et al. « A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region » Br J Dermatol. 2000;142:1177-83. PMID 10848743
(en) Lecha M, Effendy ‘I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R, « Taskforce on onychomycosis education. Treatment options-development of consensus guidelines » J Eur Acad Dermatol Venereol. 2005;19(Suppl 1):25-33. PMID 16120203
(en) Crawford F, Hollis S, « Topical treatments for fungal infections of the skin and nails of the foot » Cochrane Database Syst Rev. 2007;3:CD001434. PMID 17636672
(en) Hay RJ, Mackie RM, Clayton YM, « Tioconazole nail solution—an open study of its efficacy in onychomycosis » Clin Exp Dermatol. 1985;10:111-5. PMID 3156698
(en) T. A. Syed, « Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream », Tropical Medicine & International Health,‎ avril 1999, p. 284-287. (lire en ligne)
(en) Havu V, Brandt H, Heikkilä H. et al. « A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis » Br J Dermatol. 1997;136:230-4. PMID 9068738
(en) Gupta AK, Ryder JE, Johnson AM, « Cumulative eta-analysis of systemic antifungal agents for the treatment of onychomycosis » Br J Dermatol. 2004;150:537-44. PMID 15030339
Tosti, A., Hay, R., & Arenas‐Guzmán, R. (2005). Patients at risk of onychomycosis–risk factor identification and active prevention. Journal of the European Academy of Dermatology and Venereology, 19(s1), 13-16 |résumé
Pietro Nenoff, Constanze Krüger, Gabriele Ginter-Hanselmayer, Hans-Jürgen Tietz (2014) Mycology – an update. Part 1: Dermatomycoses: Causative agents, epidemiology and pathogenesis